HR Execs on the Move

Sanofi Genzyme

www.sanofigenzyme.com

 
Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Richard Manning
Vice President/Head Patient Support Services Dupixent Profile
Tejdip Singh
Senior Medical Director Clinical Research and Development Profile
William Bonville
Principal Auditor R&D Site Quality Operations Gene and Cell Therapy Genomics Medicine Profile
Greg Hurlbut
R&D Director/ Associate Director / Sr. Principal Scientist Profile
Scott Eisenbeis
VP R&D Strategy Profile

Similar Companies

Vitacorp International Inc

Vitacorp International Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ascend Therapeutics

Ascend Therapeutics is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Embecta

Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business

Ratio Therapeutics

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trilliumâ„¢ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.

isotechnika

isotechnika is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.